VANI
Vivani Medical Inc.
NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY
$1.34
+1.52% today
Updated 2026-04-30
Market cap
$115.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
Vivani Medical Inc. (VANI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.32M | $-17.43M | $-17.09M | $-20.55M | $-25.07M | $-23.95M | $-29.81M | $-27.63M | $-7.62M | $-10.95M | $-18.79M | $-23.70M | $-20.79M | $-24.32M |
| Capital expenditures | $196083.00 | $246004.00 | $560351.00 | $762000.00 | $490000.00 | $265000.00 | $163000.00 | $493000.00 | $150000.00 | $572000.00 | $338000.00 | $887000.00 | $556000.00 | $1.17M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $907862.00 | $769896.00 | $1.47M | $2.69M | $3.37M | $3.78M | $3.59M | $2.92M | $1.04M | $1.67M | $1.30M | $1.86M | $1.61M | $1.48M |
| Free cash flow | $-15.52M | $-17.67M | $-17.65M | $-21.31M | $-25.56M | $-24.21M | $-29.97M | $-28.12M | $-7.77M | $-11.52M | $-19.13M | $-24.59M | $-21.34M | $-25.49M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |